Saletu B, Kindshofer G, Anderer P, Grünberger J
Department of Psychiatry, School of Medicine, University of Vienna, Austria.
Int J Clin Pharmacol Res. 1987;7(5):407-18.
In a double-blind, placebo-controlled sleep-laboratory study the short-term effects of cinolazepam--a recently introduced 1,4 benzodiazepine with a half-life of 9 h--on the all-night sleep, morning awakening and early morning behaviour were investigated in 20 young normal subjects, whose sleep was experimentally disturbed by nocturnal traffic noise. The latter was prerecorded on tape and reproduced by loud speakers throughout the night with a sound pressure level of 68-90 dB(A) (energy equivalent mean noise level LAeq: 79dB(A)). According to the parallel group design subjects received either a placebo or 40 mg cinolazepam. Specifically, they spent nine nights in the sleep laboratory: two adaptation nights, one baseline night on placebo, three drug or placebo nights, and three post-drug/placebo nights under traffic noise. Somnopolygraphic investigations were carried out between 22h30 and 06h00. The drug was given orally half an hour before bedtime. Each 30 sec epoch was scored according to the criteria of Rechtschaffen and Kales. In the morning the subjects were awakened by 1000 Hz tones which were increased in loudness in 10 dB steps in two minute intervals. A sleep self-rating scale for sleep and awakening quality was completed half an hour after the morning toilet. Thereafter noopsychic and thymopsychic variables were evaluated utilizing a psychometric test battery. Statistical analyses of objective sleep variables demonstrated a significant improvement of sleep maintenance after 40 mg cinolazepam as reflected by an increase of sleep efficiency, decrease of wake time (during total sleep period) and number of awakenings as compared with the placebo. Sleep architecture was only affected slightly: sleep stage S1 decreased, S2 increased, while S3, S4 and SREM (S rapid eye movement) remained unchanged. Subjective sleep quality improved significantly as well. In the mornings there were no hangover signs, neither in subjective nor in objective psychometric and psychophysiological variables. Finally, the study suggests that man can adapt subjectively to nocturnal traffic noise over one week, although the improvement of objective sleep variables over time did not reach the level of statistical significance.
在一项双盲、安慰剂对照的睡眠实验室研究中,对20名年轻正常受试者进行了调查,研究了西诺西泮(一种最近引入的半衰期为9小时的1,4 - 苯二氮䓬类药物)对整夜睡眠、早晨觉醒和清晨行为的短期影响。这些受试者的睡眠因夜间交通噪音而受到实验性干扰。交通噪音预先录制在磁带上,通过扬声器在整个晚上以68 - 90 dB(A)的声压水平播放(能量等效平均噪音水平LAeq:79dB(A))。根据平行组设计,受试者分别接受安慰剂或40毫克西诺西泮。具体而言,他们在睡眠实验室度过了九个晚上:两个适应夜晚、一个服用安慰剂的基线夜晚、三个服用药物或安慰剂的夜晚,以及三个在交通噪音环境下的药物/安慰剂后夜晚。在22:30至06:00之间进行多导睡眠图调查。药物在睡前半小时口服。每个30秒的时段根据 Rechtschaffen 和 Kales 的标准进行评分。早晨,受试者被1000赫兹的音调唤醒,音调以10分贝的步长在两分钟间隔内逐渐增大音量。在早晨洗漱后半小时完成一份关于睡眠和觉醒质量的睡眠自评量表。此后,利用一套心理测量测试评估神经心理和精神心理变量。对客观睡眠变量的统计分析表明,与安慰剂相比,40毫克西诺西泮后睡眠维持有显著改善,表现为睡眠效率提高、(总睡眠时间内的)觉醒时间减少和觉醒次数减少。睡眠结构仅受到轻微影响:睡眠阶段S1减少,S2增加,而S3、S4和快速眼动睡眠(SREM)保持不变。主观睡眠质量也有显著改善。早晨,无论是主观还是客观的心理测量和心理生理变量中都没有宿醉迹象。最后,该研究表明,尽管随着时间推移客观睡眠变量的改善未达到统计学显著水平,但人类可以在一周内主观适应夜间交通噪音。